Home › Cardiovascular Disease › Texas › McKinney
Cardiovascular Disease clinical trials in McKinney, TX
4 studies for Cardiovascular Disease are looking for participants at sites in and around McKinney (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Revival Research Institute, LLC, McKinney
- Texas Institute of Cardiology, PA, McKinney
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, McKinney
- Clinical Trial Site, McKinney
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, McKinney
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Revival Research Institute, McKinney
- Texas Institute of Cardiology, McKinney
Cardiovascular Disease trials in other cities
- Boston, MA36 studies
- New York City, NY32 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- St. Louis, MO20 studies
- Pittsburgh, PA20 studies
- Nashville, TN19 studies
Other studies in McKinney
- Heart Failure7 studies
- Type 2 Diabetes6 studies
- Asthma5 studies
- COPD5 studies
- Obesity4 studies
- Chronic Kidney Disease4 studies
- Atherosclerosis3 studies
- Atrial Fibrillation3 studies
- Interstitial Lung Diseases3 studies
- Graves Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.